Saxenda(R) recommended for approval by European Medicines Agen...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BAGSVÆRD, Denmark, March 26, 2021, /PRNewswire-AsiaNet/-- Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has recommended that the use of Saxenda(R) is expanded for the treatment of obesity in adolescents aged 12–17 yea...
Authors: LATEST ASIANET NEWS RELEASES